PMID- 29393384 OWN - NLM STAT- MEDLINE DCOM- 20180823 LR - 20181202 IS - 1791-244X (Electronic) IS - 1107-3756 (Linking) VI - 41 IP - 4 DP - 2018 Apr TI - Carbon monoxide releasing molecule‑3 promotes the osteogenic differentiation of rat bone marrow mesenchymal stem cells by releasing carbon monoxide. PG - 2297-2305 LID - 10.3892/ijmm.2018.3437 [doi] AB - Stem cell‑based therapies are promising strategies to stimulate bone regeneration. Carbon monoxide releasing molecule‑3 (CORM‑3) exhibits multiple regulatory effects in a number of cells by releasing carbon monoxide (CO). The present study aimed to investigate the influence of CORM‑3 on the osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMSCs). BMSCs were divided into five groups: A CORM‑3‑osteogenic group, in which cells were pretreated with CORM‑3 and subjected to osteogenic differentiation induction using osteogenic medium; an osteogenic group, in which cells were cultured in osteogenic medium; a degassed CORM‑3‑osteogenic group, in which cells were pretreated with degassed CORM‑3 and subjected to osteogenic differentiation induction; a CORM‑3 group, in which cells were cultured in control medium containing CORM‑3; and a control group, in which cells were cultured in control medium alone. The osteo‑specific mRNA and protein expression of runt‑related transcription factor 2 (Runx2), osteocalcin (OCN) and osteopontin (OPN) were assessed using reverse transcription‑quantitative polymerase chain reaction and western blot analysis. Alkaline phosphatase (ALP) activity was also examined and mineralization was detected using alizarin red staining. Levels of Runx2, OCN and OPN mRNA and protein in the CORM‑3‑osteogenic group were significantly increased compared with the osteogenic group (P<0.05), with the exception of OCN protein levels on day 3. The mRNA and protein expression of Runx2, OCN and OPN in the degassed CORM‑3‑osteogenic and osteogenic groups were similar. In addition, the mRNA and protein expression of Runx2, OCN and OPN in the CORM‑3 and control group were similar. ALP activity in the CORM‑3‑osteogenic group was increased from day 3 and remained significantly higher compared with all other groups on days 3, 5 and 7 (P<0.05). Additionally, the results indicated that the optical density value of alizarin red staining in the CORM‑3‑osteogenic group was significantly increased compared with the other groups (P<0.05). Therefore, the present study demonstrated that CORM‑3 may promote the osteogenic differentiation of BMSCs by releasing CO. FAU - Li, Jingyuan AU - Li J AD - School of Dentistry, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Song, Ling AU - Song L AD - Department of Stomatology, Qingdao Municipal Hospital, Qingdao, Shandong 266011, P.R. China. FAU - Hou, Meng AU - Hou M AD - School of Stomatology, Medical College of Jining, Jining, Shandong 272000, P.R. China. FAU - Wang, Ping AU - Wang P AD - School of Dentistry, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Wei, Lingling AU - Wei L AD - School of Dentistry, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong 250012, P.R. China. FAU - Song, Hui AU - Song H AD - School of Dentistry, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Shandong University, Jinan, Shandong 250012, P.R. China. LA - eng PT - Journal Article DEP - 20180129 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - 0 (Organometallic Compounds) RN - 0 (tricarbonylchloro(glycinato)ruthenium(II)) RN - 7U1EE4V452 (Carbon Monoxide) RN - EC 3.1.3.1 (Alkaline Phosphatase) SB - IM MH - Alkaline Phosphatase/metabolism MH - Animals MH - Carbon Monoxide/*metabolism MH - Cell Differentiation/drug effects MH - Cell Proliferation/drug effects MH - Cells, Cultured MH - Male MH - Mesenchymal Stem Cells/cytology/*drug effects/metabolism MH - Organometallic Compounds/*pharmacology MH - Osteogenesis/*drug effects MH - Rats EDAT- 2018/02/03 06:00 MHDA- 2018/08/24 06:00 CRDT- 2018/02/03 06:00 PHST- 2017/08/06 00:00 [received] PHST- 2018/01/09 00:00 [accepted] PHST- 2018/02/03 06:00 [pubmed] PHST- 2018/08/24 06:00 [medline] PHST- 2018/02/03 06:00 [entrez] AID - 10.3892/ijmm.2018.3437 [doi] PST - ppublish SO - Int J Mol Med. 2018 Apr;41(4):2297-2305. doi: 10.3892/ijmm.2018.3437. Epub 2018 Jan 29.